Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma: An evaluation of response and toxicity

Laryngoscope

Volumn 115, Issue 5, 2005, Pages 806-810

  Lu, Jiade Jay ^a   Shakespeare, Thomas P ^a   Thiagarajan, Anu ^a   Zhang, Xiaojian ^b   Liang, Luke ^a   Tan, Sheng ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Concomitant boost radiation; Nasopharyngeal carcinoma; Radiotherapy

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; HUMAN; LYMPHADENOPATHY; MALE; METASTASIS; NASOPHARYNX CARCINOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; TREATMENT OUTCOME;

CARCINOMA, SQUAMOUS CELL; DYSGEUSIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NAUSEA; NEOPLASM STAGING; OLFACTION DISORDERS; OTITIS EXTERNA; PROSPECTIVE STUDIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; VOMITING; XEROSTOMIA;

EID: 18044372237     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MLG.0000157283.73284.A1     Document Type: Article

References (15)

1. Mesic JB, Flether GH, Goepfert H. Megavoltage irradiation of epithelial tumors of the nasopharynx. Int J Radiat Oncol Biol Phys 1981;7:447-453.
2. Lee AW, Law SC, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992;23:261-272.
3. Yang TS, Ng KT, Wang HM, et al. Prognostic factors of locoregionally recurrent nasopharyngeal carcinoma - a retrospective review of 182 cases. Am J Clin Oncol 1996;19:337-343.
4. Wolden SL, Zelefsky MJ, Kraus DH, et al. Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma. J Clin Oncol 2001;19:1105-1110.
5. Fischer M, Stuben G, Klahold M, et al. Accelerated hyperfractionated radiotherapy with concurrent chemotherapy in locally advanced nasopharyngeal carcinoma: a phase II study. J Cancer Res Clin Oncol 2001;127:507-511.
6. Jian JM, Cheng SH, Tsai SY. Improvement of local control of T3 andT4 nasopharyngeal carcinoma by hyperfractionated radiotherapy and concomitant chemotherapy. Int J Raiat Oncol Biol Phys 2002;53:344-352.
7. Fu KK, Pajak TF, Trotti A, et al. A Radiotherapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48:7-16.
8. Teo P, Shiu W, Leung SF, et al. Prognostic factors in nasopharyngeal carcinoma investigated by computer tomography: an analysis of 659 patients. Radiother Oncol 1992;23:79-93.
9. Al-Sarraf M, LeBlanc M, Diri PGS, et al. Chemotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol 1998;16:1310-1317.
10. Chan AT, Teo PML, Leung NT, et al. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol 2002;20:2038-2044.
11. Sanguineti G, Geara F, Garden A, et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys 1997;37:985-996.
12. Vikram B, Mishra UB, Strong EW, et al. Patterns of failure in carcinoma of the nasopharynx. I. Failure at the primary site. Int J Radiat Oncol Biol Phys 1985;11:1455-1459.
13. Teo PM, Leung SF, Chan AT, et al. Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications. Int J Raiat Oncol Biol Phys 2000;48:1311-1322.
14. Sham J, Choy D, Kwong PW, et al. Radiotherapy for nasopharyngeal carcinoma: shielding the pituitary may improve therapeutic ratio. Int J Raiat Oncol Biol Phys 1994;29:699-704.
15. Lee AW. Complications of radiotherapy. In: Van Hasselt CA, Gibb AG, eds. Nasopharyngeal Carcinoma. Hong Kong: The Chinese University Press, 1991:221-234.